Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...
Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) ...
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory ...
The Atlanta Falcons have several critical pieces set to enter a contract year in 2026, with several in line to receive an ...
Avalanche Digest on MSN
This is even better than we expected
Click the link <a href="http://kalshi.com/r/DIGESTNHL">http://kalshi.com/r/DIGESTNHL</a> or download the Kalshi App and use ...
Forge’s FUEL™ platform and cGMP manufacturing services support the production of AAV for Ascidian’s ACDN-01, the most advanced genetic therapy targeting the underlying cause of Stargardt disease ...
What started as an injury replacement after the Kings were suffering several guys out on the IR, Taylor Ward took advantage ...
Last week, biotechnology company Ascidian Therapeutics announced a manufacturing partnership with gene-therapy–focused ...
Ascidian Therapeutics (“Ascidian”), a biotechnology company seeking to treat human diseases by rewriting RNA, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and member of the ...
Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, announced the significant expansion of its gene therapy platform. Through an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results